Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults.
Anaissie
E J
EJ
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects; D001228:Aspergillosis / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009503:Neutropenia / Q000382:microbiology*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B